Rennie Rhee is a Rheumatology/Immunology physician. ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3400 Spruce St
8th Floor Penn Tower
Philadelphia, PA 191044238
Telephone
215-662-2454Registry record last updated 22 May 2014.
Clinical trials
- Vascular MRI Evaluation in Giant Cell Arteritis (VEGA)
Sponsor: University of Pennsylvania
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novartis Pharmaceuticals CorporationProgram year20244 payments
- Janssen Scientific Affairs, LLCProgram year20241 payment
- Amgen Inc.Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
38.9%Interleukin-6 Receptor Antagonist12.7%Actemra69%Actemra Actpen31%Part D<11 patientsFolate Analog Metabolic Inhibitor11.3%Methotrexate100%Part D≥13 patients+ 3 more classes in this area
Metabolism & gastrointestinal
37.3%Corticosteroid34.7%Prednisone100%Part D≥45 patientsAntidiarrheal microorganisms2.5%Folic Acid100%Part D<11 patientsAnti-infectives
7.5%Short-acting sulfonamides7.5%Sulfamethoxazole-Trimethoprim100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
4 NIH research awards on record, funded 2017–2026 per NIH RePORTER. The latest:
- Molecular and clinical predictors of relapse in ANCA-associated vasculitis
University of Pennsylvania
FY2026$482,934R01AR084646 - Establishing orbital and cranial vessel wall MRI enhancement as an imaging biomarker in giant cell arteritis
University of Pennsylvania
FY2026$230,687R01AR084199 - Molecular and clinical predictors of relapse in ANCA-associated vasculitis
University of Pennsylvania
FY2025$463,060R01AR084646
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
David Felson, MD
Boston University
Marc Hochberg, MD
University of Maryland School of Medicine
Philip Mease, MD
Michelle Petri, MD
Johns Hopkins University School of Medicine
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”